In this issue of Blood, Laidlaw and colleagues show that in subjects with aspirin exacerbated respiratory disease (AERD), dysregulated platelet-leukocyte crosstalk may be partly responsible for the respiratory tissue inflammation and overproduction of cysteinyl leukotrienes, providing new clues for the treatment of the disease.